This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
High bloodpressure, also known as hypertension, is a common condition that affects millions of people worldwide. Often referred to as the silent killer, hypertension can quietly damage your heart and other vital organs over time. What Is High BloodPressure?
BackgroundVericiguata novel oral soluble guanylate cyclase stimulatorwas developed for the treatment of chronic heartfailure (HF). We matched 75 external control patients for this purpose.
An analysis of data from a long-running study of more than 11,000 adults from four diverse communities in the United States has found that adults who had high bloodpressure while both seated upright and lying supine (flat on their backs) had a higher risk of heart disease, stroke, heartfailure or premature death compared to adults without high blood (..)
Research Highlights: The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heartfailure; however, it did not significantly impact the rate of death, new heart attack or stroke. More research is needed to further.
milla1cf Wed, 04/24/2024 - 19:01 April 24, 2024 — Hello Heart , a digital leader in preventive heart health, today announced results from its latest study observing the benefits of scalable, accessible digital health tools for a growing senior population. Eighty percent of heart attacks and strokes are preventable.
We do a terrible job of identifying and managing high bloodpressure. And we still do an awful job of identifying and managing high bloodpressure. As a risk factor for death, high bloodpressure is responsible for more deaths than any other risk factor, including smoking. What Is Normal BloodPressure?
Abstract Background Existing data on the association between bloodpressure levels and adverse cardiovascular outcomes in patients with heartfailure (HF) are inconsistent. The optimal bloodpressure targets for patients with HF remain uncertain.
An analysis based on a proposed heartfailure risk prediction tool reveals that the incidence of heartfailure may be 2- to 3-fold higher among American Indian adults compared to people in other population groups.
People with type 2 diabetes had significantly fewer heart attacks, strokes, heartfailures, and deaths from cardiovascular disease when their bloodpressure was lower than the current standard goal, a UT Southwestern Medical Center researcher and his colleagues found.
Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heartfailure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25
Background Heartfailure (HF) is a leading cause of morbidity and mortality worldwide. After adjusting for gender, age, New York Heart Association class, CKD, systolic bloodpressure (SBP) and potassium, the HUA group exhibited a higher risk for the primary endpoint compared with the NUA group (HR: 1.40, 95% CI: 1.14
Some studies suggest that moderate alcohol consumption may provide cardiovascular benefits, while excessive or binge drinking can significantly harm the heart. Understanding the effects of alcohol on heart disease, bloodpressure, and heart muscle function is essential for making informed decisions about alcohol intake.
Proposed approach for clinical management and therapeutic optimization in patients with heartfailure with reduced ejection fraction and low bloodpressure. Low bloodpressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.
The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic (Echo) markers of diastolic dysfunction, an important component in the development of heartfailure, in hypertensive patients. Advanced HeartFailure Cardiologist, Duke Health on Feb.
milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heartfailure, according to research presented at HeartFailure 2024 , a scientific congress of the European Society of Cardiology (ESC).
It found the strongest links with risks of high bloodpressure, ischemic heart disease and heartfailure. The study is the first of its kind to look at cardiovascular health after perinatal depression and included data on around 600,000 women.
We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the HeartFailure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), blocking the mineralocorticoid receptor and its bloodpressure effects. Patients treated within 7 days of a WHF event also tended to achieve lower systolic bloodpressure, lower EF, higher NT-proBNP, and worse NYHA functional class.
A study published in The Lancet reveals that targeting a systolic bloodpressure of less than 120 mm Hg significantly reduces cardiovascular events in high-risk patients, compared to the standard target of less than 140 mm Hg. Key Findings – BloodPressure Levels: The mean systolic bloodpressure during follow-up was 119.1
When you compare those in the highest fitness levels to those in the lowest fitness levels, the impact on early death, death from heart disease and cancer deaths is incredible 1. Death from heart disease: 51% reduction in risk. High BloodPressure: 37% reduction in risk. HeartFailure: 69% reduction in risk.
Preventing Heart Attacks and Cardiac Arrest Maintaining a healthy lifestyle can reduce the risk of both heart attack and cardiac arrest. Visiting the emergency room at the first sign of a heart attack can help begin treatment quickly and prevent complications like heartfailure.
Although heartfailure prognosis is grim, the ALT-FLOW trials two year results suggest that diverting blood from the left atrium to the coronary sinus using a shunt could have lasting benefits for patients with HFmrEF/HFpEF.
Both forms of enlargement may compromise the heart’s ability to pump blood efficiently, leading to further complications like heartfailure. What Causes an Enlarged Heart? High BloodPressure (Hypertension) Persistent high bloodpressure forces the heart to work harder to pump blood.
While the holidays themselves can’t cause a heart attack , certain things people do during the hectic, festive season may stress their heart health more than they realize. Plus, these stressors can increase the risk of heart attack, stroke or retention of extra fluid and heartfailure , explains Dr. Tarditi.
Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heartfailure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25
In this week’s View, Dr. Eagle covers various bloodpressure parameters and their predictability for peripheral arterial disease (PAD) and complications, then explores the five-year outcomes of leadless pacemakers.
Aims Empagliflozin improves outcomes in acute heartfailure (AHF). Patients with AHF and low bloodpressure (BP) have poor prognosis. Whether empagliflozin is effective and safe in patients with AHF and low BP is currently unknown. The aim of this study was to assess the efficacy and safety of empagliflozin (vs.
New Study Reveals 65 and Older Population Lowered BloodPressure, Cholesterol and Weight Using Mobile Technology 2. 24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack 10. Clinical trials and innovative technology took center stage during the month of April, racking up some record number views.
AVIM therapy is an investigational patented bioelectronic therapy, administered using a standard dual-chamber pacemaker, designed to immediately, substantially and persistently reduce bloodpressure. This leaves a gap in the care of these patients and increases their risk for heart attack, stroke and heartfailure progression.
These harmful substances directly impact the heart and blood vessels in several ways: Reduced Oxygen Supply: Carbon monoxide, a byproduct of smoking, binds to hemoglobin in the blood, reducing its oxygen-carrying capacity. This forces the heart to work harder to supply oxygen to tissues and organs.
Classically, activation of the MR in the renal tubular epithelium is responsible for sodium retention and volume expansion, raising systemic bloodpressure.
A projected rise in heart disease and stroke – along with several key risk factors, including high bloodpressure and obesity – is likely to triple related costs to $1.8 trillion by 2050, according to two American Heart Association ( AHA ) presidential advisories published June 4 in the AHA journal Circulation.
Abstract Aims A high-intensity care (HIC) strategy with rapid guideline-directed medical therapy (GDMT) up-titration and close follow-up visits improved outcomes, compared to usual care (UC), in patients recently hospitalized for acute heartfailure (AHF). The primary endpoint was 180-day heartfailure rehospitalization or death.
21, 2024 — The incidence rate of heartfailure was 2- to 3-fold higher among American Indian populations than rates observed in studies focused on other population groups, such as African American, Hispanic or white adults, in a new study published in the Journal of the American Heart Association.
Associations between baseline heart rate and bloodpressure and time to events in HFrEF patients: summary of the key findings. ACEi, angiotensin-converting-enzyme inhibitor; BB, beta blocker; CV, cardiovascular; HF, heartfailure; MRA, mineralocorticoid receptor antagonist; RHR, resting heart rate; SBP, systolic bloodpressure.
Apparent treatment-resistant hypertension is defined as the need to take three or more types of anti-high bloodpressure medication daily and is associated with an increased risk for stroke , coronary heart disease , heartfailure , and all-cause mortality. Over a period of 9.5 of white adults.
Low BloodPressure & HeartFailure in SwedeHF: The heightened risk associated with lower systolic bloodpressure (SBP) is reduced when higher doses of heartfailure medications are used. Aims Heartfailure (HF) medication may reduce bloodpressure (BP).
have high bloodpressure. Maintaining healthy bloodpressure can protect against serious conditions like heartfailure, heart attacks, and strokes. An estimated 80 percent of older adults in the U.S.
Background:Stage B heartfailure (HF) was associated with increased cardiovascular and HF events. Circulation, Volume 150, Issue Suppl_1 , Page A4139510-A4139510, November 12, 2024. Hypertension is a risk factor for these events in Stage B HF.
BACKGROUND:The STEP (Strategy of BloodPressure Intervention in the Elderly Hypertensive Patients) trial demonstrated that intensive systolic bloodpressure (SBP) lowering has cardiovascular benefits. Hypertension, Volume 80, Issue 12 , Page 2572-2580, December 1, 2023. years, and 46.5% were men.
An analysis of data from a long-running study of more than 11,000 adults from four diverse communities in the United States has found that adults who had high bloodpressure while both seated upright and lying supine (flat on their backs) had a higher risk of heart disease, stroke, heartfailure or premature death compared to adults without high blood (..)
The Aria CV Pulmonary Hypertension System is an implantable gas-filled balloon that is introduced percutaneously and functions in the main pulmonary artery to alleviate the excessive workload on the right heart that results in right heartfailure.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content